References

Human plasma lipoprotein[a] structural properties

10.1016/s0021-9258(18)32663-2 · 1983 · External reference

Protein-composition of Lp(a) lipoprotein from human-plasma

10.1016/0014-5793(83)80182-3 · 1983 · External reference

Relationship between apolipoprotein(a) isoforms and lipoprotein(a) levels in patients with acute coronary syndrome

2026 · External reference

Ancestral variation in lp(a): Epidemiology, isoform diversity, and testing

10.1007/s11883-025-01365-0 · 2025 · External reference

Lp(a) concentration and apo(a) isoform size - relation to the presence of coronary-artery disease in familial hypercholesterolemia

10.1161/01.atv.14.10.1561 · 1994 · External reference

Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a)

10.1253/jcj.63.659 · 1999 · External reference

Low molecular weight apolipoprotein(a) phenotype rather than lipoprotein(a) is associated with coronary atherosclerosis and myocardial infarction

10.3389/fcvm.2022.843602 · 2022 · External reference

Small apolipoprotein(a) isoforms may predict primary patency following peripheral arterial revascularization

2024 · External reference

Apolipoprotein(a) isoforms and the risk of vascular disease systematic review of 40 studies involving 58,000 participants

10.1016/j.jacc.2009.10.080 · 2010 · External reference

Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: A systematic analysis of the global burden of disease study 2021

10.1186/s12872-025-05022-x · 2025 · External reference

Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature cad in young asian indians

10.1016/j.clinbiochem.2008.01.016 · 2008 · External reference

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study (vol 364, pg 937m 2004)

10.1016/s0140-6736(04)17018-9 · 2004 · External reference

Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study

10.1016/s0140-6736(04)17019-0 · 2004 · External reference

Potentially modifiable risk factors associated with myocardial infarction in China: The INTERHEART China study

10.1136/hrt.2008.155796 · 2009 · External reference

Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups

10.1161/circulationaha.118.034311 · 2019 · External reference

Rubiés-Prat J. Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting

10.1016/s0009-8981(98)00126-0 · 1998 · External reference

Thematic review series: Lipoprotein: Coming of age at last structure, function, and genetics of lipoprotein

10.1194/jlr.r067314 · 2016 · External reference

Lipoprotein(a) beyond the kringle iv repeat polymorphism: The complexity of genetic variation in the LPA gene

10.1016/j.atherosclerosis.2022.04.003 · 2022 · External reference

The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity

10.1097/mol.0b013e328308b622 · 2008 · External reference

Determinants of binding of oxidized phospholipids on apolipoprotein and lipoprotein

10.1194/jlr.m040733 · 2013 · External reference

Oxidized phospholipids in cardiovascular disease

10.1038/s41569-023-00937-4 · 2024 · External reference

Determination of kinetic-parameters of apolipoprotein-B metabolism using amino-acids labeled with stable isotopes

10.1016/s0022-2275(20)41961-3 · 1991 · External reference

Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) messenger-rna in a cynomolgus monkey model

10.1016/s0021-9258(18)92782-1 · 1991 · External reference

Detection and quantitation of apolipoprotein(a) messenger-rna in human liver and its relationship with plasma lipoprotein(a) concentration

10.1016/0021-9150(91)90187-8 · 1991 · External reference

Lp(a) assembly and the influence of allelic variation on apo(a) secretion

1992 · External reference

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner

10.1161/01.atv.0000021144.87870.c8 · 2002 · External reference

Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes

10.1016/j.jacc.2023.02.050 · 2023 · External reference

Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors results from the dallas heart study

10.1161/circulationaha.108.836940 · 2009 · External reference

Oxidized phospholipid dynamics in the early post-infarction period: Effects of pcsk9 inhibition with evolocumab

10.1016/j.atherosclerosis.2025.120469 · 2025 · External reference

Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans

10.1161/circulationaha.116.020838 · 2016 · External reference